Concourse Financial Group Securities’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-6,303
Closed -$4.75M 1205
2024
Q4
$4.75M Sell
6,303
-444
-7% -$368K 0.27% 85
2024
Q3
$4.86M Sell
6,747
-152
-2% -$137K 0.29% 84
2024
Q2
$5.11M Buy
6,899
+597
+9% +$478K 0.32% 75
2024
Q1
$4.9M Buy
6,302
+559
+10% +$398K 0.32% 76
2023
Q4
$3.35M Buy
5,743
+1,006
+21% +$587K 0.24% 95
2023
Q3
$2.54M Buy
4,737
+339
+8% +$175K 0.2% 114
2023
Q2
$2.06M Buy
4,398
+466
+12% +$195K 0.16% 132
2023
Q1
$1.35M Sell
3,932
-282
-7% -$95.1K 0.1% 199
2022
Q4
$1.54M Sell
4,214
-267
-6% -$94.7K 0.12% 181
2022
Q3
$1.45M Sell
4,481
-123
-3% -$39K 0.14% 162
2022
Q2
$1.49M Buy
4,604
+288
+7% +$86.4K 0.13% 175
2022
Q1
$1.24M Sell
4,316
-3,378
-44% -$869K 0.09% 220
2021
Q4
$2.13M Buy
7,694
+170
+2% +$43.1K 0.12% 161
2021
Q3
$1.74M Sell
7,524
-272
-3% -$67.1K 0.11% 189
2021
Q2
$1.79M Sell
7,796
-1,075
-12% -$216K 0.11% 169
2021
Q1
$1.66M Buy
8,871
+123
+1% +$24.1K 0.12% 158
2020
Q4
$1.48M Buy
8,748
+1,222
+16% +$182K 0.11% 160
2020
Q3
$1.11M Buy
7,526
+533
+8% +$82.5K 0.1% 179
2020
Q2
$1.15M Buy
6,993
+1,213
+21% +$186K 0.11% 152
2020
Q1
$802K Sell
5,780
-105
-2% -$14.4K 0.09% 183
2019
Q4
$774K Buy
5,885
+4,057
+222% +$470K 0.08% 208
2019
Q3
$204K Sell
1,828
-4,596
-72% -$512K 0.05% 289
2019
Q2
$711K Sell
6,424
-15
-0.2% -$1.77K 0.07% 207
2019
Q1
$834K Sell
6,439
-656
-9% -$79.8K 0.09% 191
2018
Q4
$821K Buy
7,095
+4,116
+138% +$460K 0.1% 184
2018
Q3
$320K Buy
+2,979
New +$298K 0.09% 200

Other funds holding LLY

Concourse Financial Group Securities's LLY Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Eli Lilly (LLY) in Q1 2025, closing a stake of 6,303 shares — an estimated $4.75M sold.

Concourse Financial Group Securities first reported a position in LLY in Q3 2018 and held it in 26 quarters. The position peaked at $5.11M in Q2 2024. 3,920 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Eli Lilly position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 6,303 Eli Lilly shares in Q1 2025, an estimated $4.75M.
  • Concourse Financial Group Securities first reported a position in Eli Lilly in Q3 2018 and held it in 26 quarters.
  • Concourse Financial Group Securities's Eli Lilly position peaked at $5.11M in Q2 2024.
  • 3,920 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.